90Y‐ibritumomab tiuxetan radiotherapy as first‐line therapy for early stage low‐grade B‐cell lymphomas, including bulky disease
暂无分享,去创建一个
P. Mclaughlin | L. Kwak | R. Mathur | S. Neelapu | L. Sehgal | Z. Berková | J. Shah | M. Fanale | B. Pro | F. Braun | J. Romaguera | F. Samaniego | N. Fowler | V. Selvaraj | J. J. Shah | L. Feng | Lei Feng | Jorge E. Romaguera